A comprehensive view of Infections & Infectious Diseases. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.
AstraZeneca to present new data on its vaccine & immune therapies portfolio at the 34th European Congress of Clinical Microbiology & Infectious Diseases; the company will showcase 19 abstracts
Published:
April 18, 2024
by PharmaBiz (India)
|
Kao Corp and Epsilon Molecular Eng File United States Patent Application for Anti-SARS-CoV-2 Antibody
Published:
April 16, 2024
by Pharmaceutical Patent News
|
GSK's 5-in-1 meningococcal ABCWY vaccine candidate accepted for review by the FDA; vaccine aims to provide broad protection against the five most common bacterial groups that cause invasive meningococcal disease
Published:
April 16, 2024
by GSK Group (GlaxoSmithKline)
|
Microbion to present its diabetic foot infection treatment, pravibismane, at the Advanced Wound Care Summit USA on April 17; the topical treatment demonstrates promising results, reportedly decreasing ulcer size and reducing the risk of amputation
Published:
April 15, 2024
by PR Newswire
|
Shah Capital nominates two highly qualified independent director candidates for Novavax
Published:
April 15, 2024
by GlobeNewswire
|
Ask us about our Consumer Wellness market view